Functional heterogeneity of fibroblasts in primary tumors and metastases
- PMID: 39674792
- DOI: 10.1016/j.trecan.2024.11.005
Functional heterogeneity of fibroblasts in primary tumors and metastases
Abstract
Cancer-associated fibroblasts (CAFs) are abundant components of the tumor microenvironment (TME) of most solid malignancies and have emerged as key regulators of cancer progression and therapy response. Although recent technological advances have uncovered substantial CAF molecular heterogeneity at the single-cell level, defining functional roles for most described CAF populations remains challenging. With the aim of bridging CAF molecular and functional heterogeneity, this review focuses on recently identified functional interactions of CAF subtypes with malignant cells, immune cells, and other stromal cells in primary tumors and metastases. Dissecting the heterogeneous functional crosstalk of specific CAF populations with other components is starting to uncover candidate combinatorial strategies for therapeutically targeting the TME and cancer progression.
Keywords: cancer-associated fibroblasts; fibroblast heterogeneity; metastases; primary tumors; tumor microenvironment.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.Cancer Sci. 2020 Aug;111(8):2708-2717. doi: 10.1111/cas.14537. Epub 2020 Jul 11. Cancer Sci. 2020. PMID: 32573845 Free PMC article. Review.
-
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1. Mol Cancer. 2021. PMID: 34635121 Free PMC article. Review.
-
Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.OMICS. 2020 Jun;24(6):340-351. doi: 10.1089/omi.2020.0042. OMICS. 2020. PMID: 32496971
-
Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.OMICS. 2020 Jun;24(6):314-339. doi: 10.1089/omi.2020.0023. OMICS. 2020. PMID: 32496970
-
Targeting Cancer-Associated Fibroblasts: Eliminate or Reprogram?Cancer Sci. 2025 Mar;116(3):613-621. doi: 10.1111/cas.16443. Epub 2025 Jan 2. Cancer Sci. 2025. PMID: 39745128 Free PMC article. Review.
Cited by
-
Exosomal circRNAs: key modulators in breast cancer progression.Cell Death Discov. 2025 Apr 24;11(1):196. doi: 10.1038/s41420-025-02494-w. Cell Death Discov. 2025. PMID: 40274787 Free PMC article. Review.
-
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies.Bioact Mater. 2025 Jul 1;52:773-809. doi: 10.1016/j.bioactmat.2025.06.052. eCollection 2025 Oct. Bioact Mater. 2025. PMID: 40677757 Free PMC article. Review.
-
A four gene risk score model for prognosis and immune microenvironment insights in small cell lung cancer based on CAF functional-related genes.Discov Oncol. 2025 May 25;16(1):923. doi: 10.1007/s12672-025-02781-z. Discov Oncol. 2025. PMID: 40415048 Free PMC article.
-
The influence of clinical risk factors on the classification of human cancer-associated fibroblasts in PDAC and pancreatitis patients.BJC Rep. 2025 Jun 16;3(1):44. doi: 10.1038/s44276-025-00150-5. BJC Rep. 2025. PMID: 40523922 Free PMC article.
-
Cancer-Associated Fibroblasts: Immunosuppressive Crosstalk with Tumor-Infiltrating Immune Cells and Implications for Therapeutic Resistance.Cancers (Basel). 2025 Jul 28;17(15):2484. doi: 10.3390/cancers17152484. Cancers (Basel). 2025. PMID: 40805183 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical